ArticleBritish journal of cancer2014

MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases.

E Nagy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.